Analyzing the Composition of Tears and Blood for Discovery of Novel Signatures of Aggressive Prostate Cancer
NCT01514669 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 75
Last updated 2025-10-10
Summary
The purpose of this research study is to compare profiles in the blood and tears of patients with and without prostate cancer with the goal of developing a method of separating men with aggressive and non-aggressive disease.
Conditions
Sponsors & Collaborators
-
University of Arkansas
lead OTHER
Principal Investigators
-
Alan Diekman, Ph.D. · University of Arkansas
Eligibility
- Min Age
- 35 Years
- Max Age
- 85 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2012-01-01
- Primary Completion
- 2027-02-28
- Completion
- 2027-02-28
Countries
- United States
Study Locations
More Related Trials
-
Analysis of Prostate Cancer Short-Term Cultures Using Molecular Cytogenetic Methods
NCT00022919 ·Status: COMPLETED
-
Tumor-Derived FGF19
NCT06068257 ·Status: RECRUITING
-
Role of Biomarkers in Disease Progression in Samples From Patients With Acute Myeloid Leukemia
NCT01500499 ·Status: COMPLETED
-
UMCC 003 Cancer-Related Protein Biomarkers in Blood and Tumor Tissue of Patients With Cancer
NCT00900094 ·Status: COMPLETED
-
Use of Blood Biomarkers to Predict Gastric Cancer Risk
NCT04329299 ·Status: COMPLETED
-
Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers
NCT00568490 ·Status: RECRUITING
-
Blood-based Identification and Monitoring of Patients With ALK-translocated Lung Cancer
NCT02718651 ·Status: COMPLETED
-
Laboratory Study Using Samples From Patients With Non-Small Cell Lung Cancer Treated on Clinical Trial CASE-2507
NCT00907699 ·Status: WITHDRAWN
-
Studying Biomarkers in Tumor Tissue and Blood Samples From Patients With Small Cell Lung Cancer Registered on CALGB-140202
NCT01503619 ·Status: COMPLETED
-
Biomarkers in Blood and Tumor Tissue Samples From Patients With Wilms Tumor
NCT01314391 ·Status: COMPLETED
-
Study of Blood Samples From Patients With Malignant Melanoma, Metastatic Breast Cancer, Advanced Lung Cancer, Pancreatic Cancer, or Colorectal Cancer.
NCT00974610 ·Status: COMPLETED
-
Cancer DNA Detection in Blood and Urine
NCT02657863 ·Status: COMPLETED
-
Studying Biomarkers in Samples From Younger Patients With Wilms Tumor
NCT01576198 ·Status: COMPLETED
-
Study of Blood and Tissue Samples From Patients With Aggressive Non-Hodgkin B-Cell Lymphoma or Hodgkin Lymphoma
NCT00981097 ·Status: COMPLETED
-
Biomarker Expression in Samples From Young Patients With Anaplastic Large Cell Lymphoma
NCT01366170 ·Status: COMPLETED
-
Cell-Free DNA Chromatin Immunoprecipitation (ChIP) for Diagnosing Cancer
NCT06148298 ·Status: RECRUITING
-
Studying Biomarkers in Samples From Younger Patients With Malignant Germ Cell Tumor Progression
NCT01433224 ·Status: COMPLETED
-
Collection of Blood From Patients With Prostate Cancer
NCT00923221 ·Status: RECRUITING
-
Study of Hair Samples From Patients With Cancer
NCT00899691 ·Status: COMPLETED
-
Biomarkers in Urine Samples From Patients With Wilms Tumor
NCT01550393 ·Status: COMPLETED
-
Markers for Predicting Risk of Breast Cancer in Women of Different Races
NCT02574546 ·Status: WITHDRAWN
-
Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study
NCT03707574 ·Status: COMPLETED
-
Collection of Blood From Patients With Cancer
NCT00034216 ·Status: RECRUITING
-
Circulating Tumors Cells and Circulating Endothelial Cells in Renal Cell Carcinoma
NCT01173445 ·Status: COMPLETED
-
Biomarker Identification for Bladder Cancer Patients
NCT02053662 ·Status: TERMINATED